{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:11:51Z","timestamp":1792649511755,"version":"4.5.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T00:00:00Z","timestamp":1420675200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s40264-014-0255-7","type":"journal-article","created":{"date-parts":[[2015,1,7]],"date-time":"2015-01-07T15:02:55Z","timestamp":1420642975000},"page":"183-187","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Risk of Anaphylaxis with Repeated Courses of Rasburicase: A Research on Adverse Drug Events and Reports (RADAR) Project"],"prefix":"10.1007","volume":"38","author":[{"given":"Katherine C.","family":"Allen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda H.","family":"Champlain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Cotliar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Belknap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis P.","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayesh","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Trifilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,8]]},"reference":[{"issue":"19","key":"255_CR1","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1056\/NEJMra0904569","volume":"364","author":"SC Howard","year":"2011","unstructured":"Howard SC, Jones DP, Pui CH. The tumor lysis syndrome. N Engl J Med. 2011;364(19):1844\u201354.","journal-title":"N Engl J Med."},{"key":"255_CR2","unstructured":"Rasburicase [package insert]. Bridgewater: Sanofi-Aventis US LLC; 2009."},{"issue":"5 Suppl 3","key":"255_CR3","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/j.ajkd.2009.10.056","volume":"55","author":"AK Abu-Alfa","year":"2010","unstructured":"Abu-Alfa AK, Younes A. Tumor lysis syndrome and acute kidney injury: evaluation, prevention, and management. Am J Kidney Dis. 2010;55(5 Suppl 3):S1\u201313.","journal-title":"Am J Kidney Dis."},{"issue":"4","key":"255_CR4","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1586\/1744666X.1.4.549","volume":"1","author":"KA Chester","year":"2005","unstructured":"Chester KA, Baker M, Mayer A. Overcoming the immunologic response to foreign enzymes in cancer therapy. Expert Rev Clin Immunol. 2005;1(4):549\u201359.","journal-title":"Expert Rev Clin Immunol."},{"issue":"Suppl 6","key":"255_CR5","first-page":"63","volume":"20","author":"H Schellekens","year":"2005","unstructured":"Schellekens H. Factors influencing the immunogenicity of therapeutic proteins. Nephrol Dial Transplant. 2005;20(Suppl 6):63\u20139.","journal-title":"Nephrol Dial Transplant."},{"issue":"10","key":"255_CR6","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1001\/archinte.167.10.1041","volume":"167","author":"CL Bennett","year":"2007","unstructured":"Bennett CL, Nebeker JR, Yarnold PR, et al. Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers. Arch Intern Med. 2007;167(10):1041\u20139.","journal-title":"Arch Intern Med."},{"issue":"17","key":"255_CR7","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1001\/jama.293.17.2131","volume":"293","author":"CL Bennett","year":"2005","unstructured":"Bennett CL, Nebeker JR, Lyons EA, et al. The Research on Adverse Drug Events and Reports (RADAR) project. JAMA. 2005;293(17):2131\u201340.","journal-title":"JAMA."},{"issue":"6","key":"255_CR8","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/bmt.2010.212","volume":"46","author":"SM Trifilio","year":"2011","unstructured":"Trifilio SM, Pi J, Zook J, et al. Effectiveness of a single 3-mg rasburicase dose for the management of hyperuricemia in patients with hematological malignancies. Bone Marrow Transplant. 2011;46(6):800\u20135.","journal-title":"Bone Marrow Transplant."},{"issue":"11","key":"255_CR9","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/sj.bmt.1705379","volume":"37","author":"S Trifilio","year":"2006","unstructured":"Trifilio S, Gordon L, Singhal S, et al. Reduced-dose rasburicase (recombinant xanthine oxidase) in adult cancer patients with hyperuricemia. Bone Marrow Transplant. 2006;37(11):997\u20131001.","journal-title":"Bone Marrow Transplant."},{"issue":"1","key":"255_CR10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2004.05094.x","volume":"127","author":"MS Cairo","year":"2004","unstructured":"Cairo MS, Bishop M. Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol. 2004;127(1):3\u201311.","journal-title":"Br J Haematol."},{"issue":"10","key":"255_CR11","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1093\/ndt\/gfp330","volume":"24","author":"M Shimada","year":"2009","unstructured":"Shimada M, Johnson RJ, May WS Jr, et al. A novel role for uric acid in acute kidney injury associated with tumour lysis syndrome. Nephrol Dial Transplant. 2009;24(10):2960\u20134.","journal-title":"Nephrol Dial Transplant."},{"issue":"1","key":"255_CR12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2215\/CJN.00350106","volume":"2","author":"AA Ejaz","year":"2007","unstructured":"Ejaz AA, Mu W, Kang DH, et al. Could uric acid have a role in acute renal failure? Clin J Am Soc Nephrol. 2007;2(1):16\u201321.","journal-title":"Clin J Am Soc Nephrol."},{"issue":"1","key":"255_CR13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/biot.200700214","volume":"3","author":"T Dingermann","year":"2008","unstructured":"Dingermann T. Recombinant therapeutic proteins: production platforms and challenges. Biotechnol J. 2008;3(1):90\u20137.","journal-title":"Biotechnol J."},{"issue":"4","key":"255_CR14","first-page":"433","volume":"3","author":"CH Pui","year":"2002","unstructured":"Pui CH. Rasburicase: a potent uricolytic agent. Pharmacother. 2002;3(4):433\u201342.","journal-title":"Pharmacother."},{"issue":"Suppl5","key":"255_CR15","doi-asserted-by":"crossref","first-page":"v9","DOI":"10.1093\/ndt\/gfl476","volume":"21","author":"M Kessler","year":"2006","unstructured":"Kessler M, Goldsmith D, Schellekens H. Immunogenicity of biopharmaceuticals. Nephrol Dial Transplant. 2006;21(Suppl5):v9\u201312.","journal-title":"Nephrol Dial Transplant."},{"key":"255_CR16","unstructured":"Rasburicase [package insert]. New York: Sanfoi-Synthelabo Inc; 2002."}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-014-0255-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40264-014-0255-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-014-0255-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T19:41:34Z","timestamp":1559504494000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40264-014-0255-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,8]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["255"],"URL":"https:\/\/doi.org\/10.1007\/s40264-014-0255-7","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,8]]}}}